Literature DB >> 6152889

Labeling of eukaryotic messenger RNA 5' terminus with phosphorus -32: use of tobacco acid pyrophosphatase for removal of cap structures.

R E Lockard1, L Rieser, J N Vournakis.   

Abstract

In recent years, there has been a growing appreciation of the potential applications of 5'-32P-end-labeled mRNA, not only for screening recombinant clones and mapping gene structure, but also for revealing possible nucleotide sequence and structural signals within mRNA molecules themselves, which may be important for eukaryotic mRNA processing and turnover and for controlling differential rates of translational initiation. Three major problems, however, have retarded progress in this area, lack of methods for efficient and reproducible removal of m7G5ppp5'-cap structures, which maintain the integrity of an RNA molecule; inability to generate a sufficient amount of labeled mRNA, owing to the limited availability of most pure mRNA species; and the frequent problem of RNA degradation during in vitro end-labeling owing to RNAse contamination. The procedures presented here permit one to decap and label minute quantities of mRNA, effectively. Tobacco acid pyrophosphatase is relatively efficient in removing cap structures from even nanogram quantities of available mRNA, and enough radioactivity can be easily generated from minute amounts ofintact mRNA with very high-specific-activity [gamma-32P]ATP and the inhibition of ribonuclease contamination with diethylpyrocarbonate. These procedures can be modified and applied to almost any other type of RNA molecule as well. In Section III of this volume, we explore in detail how effectively 5'-end-labeled mRNA can be used not only for nucleotide sequence analysis, but also for mapping mRNA secondary structure.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6152889

Source DB:  PubMed          Journal:  Gene Amplif Anal        ISSN: 0275-2778


  5 in total

1.  Concurrent sequence analysis of 5' and 3' RNA termini by intramolecular circularization reveals 5' nontemplated bases and 3' terminal heterogeneity for lymphocytic choriomeningitis virus mRNAs.

Authors:  B J Meyer; P J Southern
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

2.  Sequence heterogeneity in the termini of lymphocytic choriomeningitis virus genomic and antigenomic RNAs.

Authors:  B J Meyer; P J Southern
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

3.  Small RNA expression profiling by high-throughput sequencing: implications of enzymatic manipulation.

Authors:  Fanglei Zhuang; Ryan T Fuchs; G Brett Robb
Journal:  J Nucleic Acids       Date:  2012-06-20

4.  Application of a Schizosaccharomyces pombe Edc1-fused Dcp1-Dcp2 decapping enzyme for transcription start site mapping.

Authors:  David R Paquette; Jeffrey S Mugridge; David E Weinberg; John D Gross
Journal:  RNA       Date:  2017-11-03       Impact factor: 4.942

5.  An Ago2-associated capped transcriptional start site small RNA suppresses adenovirus DNA replication.

Authors:  Wael Kamel; Göran Akusjärvi
Journal:  RNA       Date:  2017-08-24       Impact factor: 4.942

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.